Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nieves Velez de Mendizabal

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Pharmacokinetics|August 11, 2021
Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric ModelLisa Ferguson-Sells, Nieves Velez de Mendizabal, Baohui Li, et al.
Journal of Clinical Pharmacology|June 8, 2018
Exposure-Response Modeling to Characterize the Relationship Between Ixekizumab Serum Drug Concentrations and Efficacy Responses at Week 12 in Patients With Moderate to Severe Plaque PsoriasisEmmanuel Chigutsa, Nieves Velez de Mendizabal, Laiyi Chua, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 24, 2015
A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in ratsNieves Velez de Mendizabal, Kimberley Jackson, Brian Eastwood, et al.
Plos One|March 19, 2013
Exploring the morphospace of communication efficiency in complex networksJoaquín Goñi, Andrea Avena-Koenigsberger, Nieves Velez de Mendizabal, et al.
BMC Systems Biology|April 27, 2013
Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunitySara Martinez-Pasamar, Elena Abad, Beatriz Moreno, et al.
Plos One|September 17, 2013
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approachNieves Velez de Mendizabal, Matthew M Hutmacher, Iñaki F Troconiz, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2024
Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus InfectionClémence Boivin-Champeaux, Nieves Velez de Mendizabal, Aksana Jones, et al.
Journal of Clinical and Experimental Neuropsychology|September 14, 2010
Lexical access changes in patients with multiple sclerosis: a two-year follow-up studyJorge Sepulcre, Herminia Peraita, Joaquin Goni, et al.
British Journal of Clinical Pharmacology|August 11, 2021
Population pharmacokinetic and exposure-efficacy analysis of ixekizumab in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)Kimberley Jackson, Laiyi Chua, Nieves Velez de Mendizabal, et al.
Critical Care Medicine|July 31, 2013
Therapeutic hypothermia decreases phenytoin elimination in children with traumatic brain injuryPhilip E Empey, Nieves Velez de Mendizabal, Michael J Bell, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Pharmacokinetics|August 11, 2021
Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric ModelLisa Ferguson-Sells, Nieves Velez de Mendizabal, Baohui Li, et al.
Journal of Clinical Pharmacology|June 8, 2018
Exposure-Response Modeling to Characterize the Relationship Between Ixekizumab Serum Drug Concentrations and Efficacy Responses at Week 12 in Patients With Moderate to Severe Plaque PsoriasisEmmanuel Chigutsa, Nieves Velez de Mendizabal, Laiyi Chua, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 24, 2015
A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in ratsNieves Velez de Mendizabal, Kimberley Jackson, Brian Eastwood, et al.
Plos One|March 19, 2013
Exploring the morphospace of communication efficiency in complex networksJoaquín Goñi, Andrea Avena-Koenigsberger, Nieves Velez de Mendizabal, et al.
BMC Systems Biology|April 27, 2013
Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunitySara Martinez-Pasamar, Elena Abad, Beatriz Moreno, et al.
Plos One|September 17, 2013
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approachNieves Velez de Mendizabal, Matthew M Hutmacher, Iñaki F Troconiz, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2024
Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus InfectionClémence Boivin-Champeaux, Nieves Velez de Mendizabal, Aksana Jones, et al.
Journal of Clinical and Experimental Neuropsychology|September 14, 2010
Lexical access changes in patients with multiple sclerosis: a two-year follow-up studyJorge Sepulcre, Herminia Peraita, Joaquin Goni, et al.
British Journal of Clinical Pharmacology|August 11, 2021
Population pharmacokinetic and exposure-efficacy analysis of ixekizumab in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS)Kimberley Jackson, Laiyi Chua, Nieves Velez de Mendizabal, et al.
Critical Care Medicine|July 31, 2013
Therapeutic hypothermia decreases phenytoin elimination in children with traumatic brain injuryPhilip E Empey, Nieves Velez de Mendizabal, Michael J Bell, et al.
Pageof 2